Renaissance Technologies’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-825,800
| Closed | -$15.3M | – | 4276 |
|
|
2023
Q3 | $15.3M | Sell |
825,800
-53,600
| -6% | -$606K | 0.03% | 695 |
|
|
2023
Q2 | $9.73M | Sell |
879,400
-170,800
| -16% | -$2.38M | 0.01% | 1044 |
|
|
2023
Q1 | $14.1M | Buy |
1,050,200
+341,900
| +48% | +$5.92M | 0.02% | 905 |
|
|
2022
Q4 | $8.76M | Sell |
708,300
-30,900
| -4% | -$438K | 0.01% | 1169 |
|
|
2022
Q3 | $10.3M | Buy |
739,200
+345,800
| +88% | +$5.57M | 0.01% | 1015 |
|
|
2022
Q2 | $5.43M | Buy |
393,400
+178,200
| +83% | +$2.85M | 0.01% | 1490 |
|
|
2022
Q1 | $3.5M | Sell |
215,200
-28,369
| -12% | -$444K | ﹤0.01% | 1826 |
|
|
2021
Q4 | $3.97M | Buy |
243,569
+43,969
| +22% | +$741K | ﹤0.01% | 1670 |
|
|
2021
Q3 | $2.96M | Buy |
+199,600
| New | +$3.19M | ﹤0.01% | 1792 |
|
|
2021
Q2 | – | Sell |
-35,600
| Closed | -$822K | – | 3873 |
|
|
2021
Q1 | $822K | Sell |
35,600
-401,400
| -92% | -$11.2M | ﹤0.01% | 2694 |
|
|
2020
Q4 | $10.8M | Buy |
437,000
+192,300
| +79% | +$6.37M | 0.01% | 1109 |
|
|
2020
Q3 | $10.1M | Sell |
244,700
-75,500
| -24% | -$3.47M | 0.01% | 1126 |
|
|
2020
Q2 | $15.3M | Buy |
320,200
+13,800
| +5% | +$1.07M | 0.01% | 972 |
|
|
2020
Q1 | $19.3M | Buy |
306,400
+214,200
| +232% | +$19.2M | 0.02% | 791 |
|
|
2019
Q4 | $11.4M | Buy |
+92,200
| New | +$8.25M | 0.01% | 1361 |
|
|
2017
Q3 | – | Sell |
-5,100
| Closed | -$617K | – | 3422 |
|
|
2017
Q2 | $617K | Buy |
+5,100
| New | +$591K | ﹤0.01% | 2710 |
|
|
2015
Q4 | – | Sell |
-61,600
| Closed | -$10.2M | – | 3476 |
|
|
2015
Q3 | $10.2M | Buy |
61,600
+200
| +0.3% | +$44K | 0.02% | 926 |
|
|
2015
Q2 | $14.8M | Buy |
+61,400
| New | +$16.4M | 0.03% | 706 |
|
|
2014
Q2 | – | Sell |
-6,500
| Closed | -$2.14M | – | 3038 |
|
|
2014
Q1 | $2.14M | Buy |
+6,500
| New | +$2.19M | 0.01% | 1734 |
|
Renaissance Technologies's ICPT Position: Q4 2023 in Review
Renaissance Technologies sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 825,800 shares — an estimated $15.3M sold.
Renaissance Technologies first reported a position in ICPT in Q1 2014 and held it in 19 quarters. The position peaked at $19.3M in Q1 2020. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Renaissance Technologies reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Renaissance Technologies sold 825,800 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $15.3M.
- Renaissance Technologies first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 19 quarters.
- Renaissance Technologies's Intercept Pharmaceuticals, Inc. position peaked at $19.3M in Q1 2020.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.